Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 1, p. 16, doi. 10.1007/s12272-021-01307-9
- By:
- Publication type:
- Article
Works matching IS 02536269 AND DT 2021 AND VI 44 AND IP 1
Results: 8
1
2
Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 1, p. 63, doi. 10.1007/s12272-021-01306-w
- By:
- Publication type:
- Article
3
Skin barrier dysfunction and filaggrin.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 1, p. 36, doi. 10.1007/s12272-021-01305-x
- By:
- Publication type:
- Article
4
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 1, p. 99, doi. 10.1007/s12272-020-01301-7
- By:
- Publication type:
- Article
5
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 1, p. 84, doi. 10.1007/s12272-020-01299-y
- By:
- Publication type:
- Article
6
IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn's disease and new therapeutic targets.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 1, p. 117, doi. 10.1007/s12272-020-01296-1
- By:
- Publication type:
- Article
7
Pathological angiogenesis and inflammation in tissues.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 1, p. 1, doi. 10.1007/s12272-020-01287-2
- By:
- Publication type:
- Article
8
Activation of β2 adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 1, p. 49, doi. 10.1007/s12272-020-01280-9
- By:
- Publication type:
- Article